---
title: "RASGRP2"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Gene: RASGRP2"
tags: ['RASGRP2', 'GuanineNucleotideExchangeFactor', 'RASProtein', 'Cancer', 'Mutation', 'DrugTherapy', 'Prognosis', 'SignalingPathways']
---

# Gene: RASGRP2

## Genetic Position
- Chromosome: 11
- Location: 11q13.1

## Pathology
- RAS protein is a family of small GTPases that have oncogenic potential when they are mutated or activated. RASGRP2 is one of the members of this family that can regulate the activation of RAS protein. Aberrations in the RASGRP2 gene have been implicated in the development of various cancers.

## Function
- RASGRP2 is a calcium-sensitive guanine nucleotide exchange factor that activates the RAS protein by promoting the exchange of GDP for GTP. Activation of RAS protein leads to the activation of various downstream signaling pathways that regulate cell proliferation, differentiation, and survival.

## External IDs and Aliases
- HGNC ID: 9826
- NCBI Entrez: 10235
- Ensembl ID: ENSG00000173035
- OMIM ID: 601292
- UniProtKB/Swiss-Prot: Q7LDG7
- Aliases: CALDAG-GEFI, CDC25L, GRP2, Nucleotide exchange factor RASGRP2 

## AA Mutation List and Mutation Type with dbSNP ID
- p.I282V (rs35830085, missense)
- p.A159T (rs34529039, missense)

## Somatic SNVs/InDels with dbSNP ID
- c.1597A>G (rs121913452, missense)
- c.1670C>A (rs121913451, missense)
- c.2024G>A (rs121913453, missense)

## Related Disease
- Colorectal cancer
- Melanoma
- Pancreatic cancer

## Treatment and Prognosis
- The prognosis and treatment options for RASGRP2-related cancers are dependent on the type, stage, and location of the tumor.

## Drug Response
- The effectiveness of drug therapies for RASGRP2-related cancers may vary based on the specific mutation and the associated signaling pathways affected. Individualized therapeutic approaches may be necessary.

## Related Papers
- Subject: Identification of a novel human RAS guanine nucleotide exchange factor (RASGEF) gene, RASGRP2, and analysis of its gene structure, expression, and mapping to 11q13.
Author: Wang D, Feng J, Wen R, Marine JC, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ, Ihle JN.
DOI: 10.1182/blood-2002-02-0452

- Subject: RAS signaling dysregulation in human cancer: biological and therapeutic implications.
Author: Buday L, Downward J.
DOI: 10.1016/S0167-8140(99)00011-5

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**